--- title: "NEAUTUS Closes Up 71.6% to $69" type: "News" locale: "en" url: "https://longbridge.com/en/news/305134178.md" description: "On debut today, NEAUTUS +28.800 (+71.642%) opened at $51.3, up 27.6% from the listing price of $40.2. Peaking/ bottoming at $88.1/51.25, the stock closed at $69, up 71.6% from the listing price of $40.2, on volume of 2.73 million shares and turnover of $193.74 million. Excluding handling fee, the book gain was $1,440 per board lot size of 50 shares.(HK stocks quote is delayed for at least 15 mins.)" datetime: "2026-11-11T08:25:11.000Z" locales: - [zh-CN](https://longbridge.com/zh-CN/news/305134178.md) - [en](https://longbridge.com/en/news/305134178.md) - [zh-HK](https://longbridge.com/zh-HK/news/305134178.md) generator: "portal-rs" --- # NEAUTUS Closes Up 71.6% to $69 On debut today, NEAUTUS(02206.HK) +28.800 (+71.642%) opened at $51.3, up 27.6% from the listing price of $40.2. Peaking/ bottoming at $88.1/51.25, the stock closed at $69, up 71.6% from the listing price of $40.2, on volume of 2.73 million shares and turnover of $193.74 million. Excluding handling fee, the book gain was $1,440 per board lot size of 50 shares. (HK stocks quote is delayed for at least 15 mins.) ### Related Stocks - [02206.HK](https://longbridge.com/en/quote/02206.HK.md) ## Related News & Research - [Nio Firefly debuts Haven special edition in Oslo, plans spring 2027 launch in Europe](https://longbridge.com/en/news/306380548.md) - [Starknet: Scheduled unlock releases up to 127 million STRK - 15 Dec 2026](https://longbridge.com/en/news/306371387.md) - [Persona Earns CEN/TS 18099 High Certification for Injection Attack Detection](https://longbridge.com/en/news/306371119.md) - [FlatRx Publishes a Dated Price Comparison of Compounded Tirzepatide at 27 U.S. Telehealth Programs Counted at a 10 mg Weekly Dose](https://longbridge.com/en/news/306369437.md) - [Dutch court bars EU sales of BYD Ti7, citing infringement of Land Rover Defender design rights](https://longbridge.com/en/news/306379119.md) --- > **Disclaimer: This article is for reference only and does not constitute any investment advice.**